The XTLB news vis-à-vis the HCV program is not a surprise; as far as I can tell, no one who is knowledgeable in the HCV arena thought XTLB was a serious player there.
This post from 2006 is worth reading (or rereading) in light of what has transpired: #msg-12350273. Regards, Dew
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”